Published in Am J Respir Crit Care Med on June 14, 2012
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet (2013) 8.18
Epidemiology and disease burden of tuberculosis in children: a global perspective. Infect Drug Resist (2014) 1.16
Tuberculosis vaccines and prevention of infection. Microbiol Mol Biol Rev (2014) 1.03
Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON-TB gold in-tube in young children evaluated for tuberculosis in Southern India. Pediatr Infect Dis J (2014) 0.92
Vaccine against tuberculosis: what's new? BMC Infect Dis (2014) 0.88
Transformative tools for tackling tuberculosis. J Exp Med (2015) 0.87
Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohort. PLoS One (2014) 0.86
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool. Immunol Rev (2015) 0.86
Smoking, BCG and employment and the risk of tuberculosis infection in HIV-infected persons in South Africa. PLoS One (2012) 0.84
Concordant or discordant results by the tuberculin skin test and the quantiFERON-TB test in children reflect immune biomarker profiles. Genes Immun (2014) 0.84
TBNET - Collaborative research on tuberculosis in Europe. Eur J Microbiol Immunol (Bp) (2012) 0.84
Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure. PLoS One (2014) 0.83
Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting. Am J Respir Crit Care Med (2015) 0.82
Priming with recombinant auxotrophic BCG expressing HIV-1 Gag, RT and Gp120 and boosting with recombinant MVA induces a robust T cell response in mice. PLoS One (2013) 0.81
Recommendations for pediatric tuberculosis vaccination in Italy. Hum Vaccin Immunother (2016) 0.77
Epidemiology of childhood tuberculosis in Switzerland between 1996 and 2011. Eur J Pediatr (2013) 0.77
Performance of the Interferon Gamma Release Assays in Tuberculosis Disease in Children Five Years Old or Less. PLoS One (2015) 0.76
Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm). BMC Infect Dis (2016) 0.75
BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers. Clin Infect Dis (2016) 0.75
Recommendations for the diagnosis of pediatric tuberculosis. Eur J Clin Microbiol Infect Dis (2016) 0.75
Alternative Quantiferon cytokines for diagnosis of children with active tuberculosis and HIV co-infection in Ghana. Med Microbiol Immunol (2017) 0.75
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med (2008) 9.49
Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet (2006) 7.82
Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. Chapter 1: introduction and diagnosis of tuberculosis in children. Int J Tuberc Lung Dis (2006) 4.83
Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet (2005) 4.82
The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis (2004) 4.82
The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med (2002) 4.72
The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J (2009) 3.86
Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J (2010) 3.81
The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J (2011) 2.47
T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med (2009) 2.34
Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One (2009) 2.34
New vaccines for tuberculosis. Lancet (2010) 2.14
Sexual inequality in tuberculosis. PLoS Med (2009) 2.06
Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis (2011) 1.89
The history of tuberculosis. Respir Med (2006) 1.70
A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children. Thorax (2010) 1.70
Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax (2006) 1.61
Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics (2006) 1.56
T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis (2007) 1.35
Adult-to-child transmission of tuberculosis: household or community contact? Int J Tuberc Lung Dis (2003) 1.31
Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin Dev Immunol (2010) 1.29
Secondary attack rate of tuberculosis in urban households in Kampala, Uganda. PLoS One (2011) 1.19
Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa. Int J Tuberc Lung Dis (2011) 1.18
Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics (2009) 1.14
BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. Vaccine (2009) 1.05
Whole blood interferon-gamma responses to mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda. PLoS One (2008) 0.99
Immunology and pathogenesis of childhood TB. Paediatr Respir Rev (2010) 0.96
Interferon-γ release assay for the diagnosis of latent tuberculosis in children younger than 5 years of age. Pediatr Infect Dis J (2011) 0.95
Immune-based diagnostics for TB in children: what is the evidence? Paediatr Respir Rev (2010) 0.90
Gender differences and inflammation: an in vitro model of blood cells stimulation in prepubescent children. J Inflamm (Lond) (2010) 0.90
Concordance of a positive tuberculin skin test and an interferon gamma release assay in bacille Calmette-Guérin vaccinated persons. Int J Tuberc Lung Dis (2011) 0.89
Blood tests for diagnosis of tuberculosis. Lancet (2006) 0.89
Interferon-gamma release assay performance for diagnosing tuberculosis disease in 0- to 5-year-old children. Pediatr Infect Dis J (2011) 0.85
QuantiFERON-TB Gold In-Tube as help for the diagnosis of tuberculosis in a French pediatric hospital. Diagn Microbiol Infect Dis (2010) 0.85
Significance of reduced reactivity in ELISPOT assay to RD antigens of Mycobacterium tuberculosis in BCG vaccinated individuals exposed to a patient with tuberculosis. Virulence (2010) 0.78
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis (2010) 5.14
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis (2012) 4.60
A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med (2007) 4.07
Paediatric tuberculosis. Lancet Infect Dis (2008) 3.97
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J (2012) 3.00
Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA (2011) 2.90
IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol (2007) 2.75
Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet (2002) 2.63
Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest (2007) 2.38
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J (2013) 2.20
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence. Eur Respir J (2013) 2.08
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest (2011) 1.89
Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study. Am J Respir Crit Care Med (2015) 1.71
Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India. PLoS One (2011) 1.70
Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India. PLoS One (2012) 1.69
A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc Natl Acad Sci U S A (2006) 1.64
Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis (2002) 1.59
Cost-effectiveness of treating latent tuberculous infection: a step towards elimination? Int J Tuberc Lung Dis (2013) 1.58
Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study. Am J Respir Crit Care Med (2009) 1.54
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB. Eur Respir J (2012) 1.54
Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr (2006) 1.49
Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement. Eur Respir J (2012) 1.44
Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis (2008) 1.43
Tuberculosis elimination: theory and practice in Europe. Eur Respir J (2014) 1.42
Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS One (2008) 1.32
Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child (2009) 1.29
Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis. Clin Diagn Lab Immunol (2002) 1.29
Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5. Science (2006) 1.27
Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One (2011) 1.22
A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine. J Neurovirol (2005) 1.19
Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy (2007) 1.17
Human Metapneumovirus as a causative agent of acute bronchiolitis in infants. J Clin Virol (2004) 1.12
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir Ther (2008) 1.12
Childhood tuberculosis: progress requires an advocacy strategy now. Eur Respir J (2012) 1.11
Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control. Clin Chest Med (2009) 1.10
Evaluation of non-culture diagnosis of invasive meningococcal disease by polymerase chain reaction (PCR). FEMS Immunol Med Microbiol (2003) 1.09
Toxicity and tolerability of fluoroquinolone-based preventive therapy for childhood contacts of multidrug-resistant tuberculosis. Pediatr Infect Dis J (2014) 1.08
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. Clin Vaccine Immunol (2013) 1.07
Latent tuberculosis infection and associated risk factors among undergraduate healthcare students in Italy: a cross-sectional study. BMC Infect Dis (2013) 1.06
CD4 and CD8 T-cell responses to mycobacterial antigens in African children. Am J Respir Crit Care Med (2010) 1.04
Failure to control growth of mycobacteria in blood from children infected with human immunodeficiency virus and its relationship to T cell function. J Infect Dis (2003) 1.01
History of tuberculosis and drug resistance. N Engl J Med (2013) 1.01
Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis (2013) 1.01
Childhood tuberculosis: out of sight, out of mind? Trans R Soc Trop Med Hyg (2007) 1.00
Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis. Clin Dev Immunol (2012) 1.00
Off-label antibiotic use in children in three European countries. Eur J Clin Pharmacol (2010) 1.00
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. BMC Infect Dis (2005) 0.99
Paediatric emergency care in resource-limited settings. Lancet (2013) 0.99
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J (2012) 0.99
Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates. Pediatr Infect Dis J (2015) 0.98
High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, India. PLoS One (2013) 0.98
Current understanding of the immune response to tuberculosis in children. Curr Opin Infect Dis (2012) 0.98
Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review. Eur Respir J (2013) 0.98
Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs. Curr Opin Pulm Med (2012) 0.97
Early deaths during tuberculosis treatment are associated with depressed innate responses, bacterial infection, and tuberculosis progression. J Infect Dis (2011) 0.96
Immunology and pathogenesis of childhood TB. Paediatr Respir Rev (2010) 0.96
Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy. BMC Public Health (2011) 0.96
Enteral L-arginine supplementation for prevention of necrotizing enterocolitis in very low birth weight neonates: a double-blind randomized pilot study of efficacy and safety. JPEN J Parenter Enteral Nutr (2013) 0.96
Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection. AIDS (2014) 0.96
Soluble ecto-5'-nucleotidase (5'-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine. J Biol Chem (2013) 0.95
Perinatal tuberculosis: new challenges in the diagnosis and treatment of tuberculosis in infants and the newborn. Early Hum Dev (2008) 0.95
Enhanced anti-mycobacterial immunity in children with erythema nodosum and a positive tuberculin skin test. J Invest Dermatol (2007) 0.94
Drug-resistant tuberculosis among foreign-born persons in Italy. Eur Respir J (2012) 0.94
Prevalence study of Legionella spp. contamination in ferries and cruise ships. BMC Public Health (2006) 0.94
Cost of tuberculosis in the era of multidrug resistance: will it become unaffordable? Eur Respir J (2012) 0.93
Achieving comprehensive childhood immunization: an analysis of obstacles and opportunities in The Gambia. Health Policy Plan (2013) 0.92
The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination. AIDS (2015) 0.91
Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Eur Respir J (2013) 0.91
Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat. Cardiovasc Res (2006) 0.90
Availability of anti-tuberculosis drugs in Europe. Eur Respir J (2012) 0.90
Potential role for IL-2 ELISpot in differentiating recent and remote infection in tuberculosis contact tracing. PLoS One (2010) 0.89
Blood tests for diagnosis of tuberculosis. Lancet (2006) 0.89
Update in tuberculosis and nontuberculous mycobacterial disease 2010. Am J Respir Crit Care Med (2011) 0.89
Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit. New Microbiol (2014) 0.88
Immunogenic Mycobacterium africanum strains associated with ongoing transmission in The Gambia. Emerg Infect Dis (2013) 0.88
Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives. Curr Opin Pulm Med (2010) 0.88
[DRGs at high risk of inappropriateness: an economic analysis of different health care delivery modalities (outpatient versus inpatient) in a university hospital (Italy).]. Ig Sanita Pubbl (2008) 0.88
Comparing neonatal and paediatric antibiotic prescribing between hospitals: a new algorithm to help international benchmarking. J Antimicrob Chemother (2012) 0.87
Longitudinal study of two cases of progressive multifocal leukoencephalopathy with a clinical benign evolution. J Neurovirol (2007) 0.87
How to use: interferon γ release assays for tuberculosis. Arch Dis Child Educ Pract Ed (2013) 0.86
Early phase clinical trials with human immunodeficiency virus-1 and malaria vectored vaccines in The Gambia: frontline challenges in study design and implementation. Am J Trop Med Hyg (2014) 0.86
miRNA signatures in sera of patients with active pulmonary tuberculosis. PLoS One (2013) 0.86
Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients. Clin Vaccine Immunol (2007) 0.85
What statistical method should be used to evaluate risk factors associated with dmfs index? Evidence from the National Pathfinder Survey of 4-year-old Italian children. Community Dent Oral Epidemiol (2009) 0.85
Treatment of tuberculosis: have we turned the corner? Lancet (2012) 0.85
Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases. Thorax (2012) 0.84
Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients. Eur J Immunol (2014) 0.83
Short communication: prevalence of antibodies against Coxiella burnetii (Q fever) in children in The Gambia, West Africa. Trop Med Int Health (2013) 0.83
Knowledge about tuberculosis among undergraduate health care students in 15 Italian universities: a cross-sectional study. BMC Public Health (2014) 0.83
Neonatal admissions, quality of care and outcome: 4 years of inpatient audit data from The Gambia's teaching hospital. Paediatr Int Child Health (2015) 0.83
TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia. J Infect Dev Ctries (2013) 0.82
Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome. J Allergy Clin Immunol (2012) 0.82
Specific antibodies against vaccine-preventable infections: a mother-infant cohort study. BMJ Open (2013) 0.82
Serogroup W135 meningococcal disease, The Gambia, 2012. Emerg Infect Dis (2013) 0.82
Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up. Eur J Pediatr (2013) 0.82
Vaccination of healthy children against seasonal influenza: a European perspective. Pediatr Infect Dis J (2013) 0.82
Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. FASEB J (2011) 0.81
Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity. HIV Clin Trials (2006) 0.81